Idiopathic pulmonary fibrosis (IPF) is a devastating and common chronic lung disease
pathologically characterized by loss of epithelial cells and activation of fibroblasts and …

Pulmonary fibrosis (PF) is a lethal, chronic and progressive respiratory disease leading to
interstitial lung damage and serious breathing problems. The pathogenic mechanism …

Pulmonary fibrosis (PF) is a disease-refractive lung condition with an increased rate of
mortality. The potential factors causing PF include viral infections, radiation exposure, and …

Pulmonary fibrosis (PF) poses a huge burden to the patients and society due to lack of an
effective treatment drug. Activation of fibrocyte, fibroblast and myofibroblasts are important …

Idiopathic pulmonary fibrosis (IPF) is a fatal respiratory disease with a poor prognosis
characterized by transforming growth factor (TGF)‐β‐induced proliferation, migration, and …

Idiopathic pulmonary fibrosis (IPF) is one of the most common and devastating interstitial
lung diseases with poor prognosis. Currently, few effective drugs are available for IPF …

Pulmonary fibrosis (PF) is the devastating consequence of various inflammatory diseases of
the lung. PF leads to a reduction of lung function, respiratory failure, and death. Several …

Background Pulmonary fibrosis (PF) is a difficult clinical condition with no effective treatment
and a high mortality rate. Patients usually die of respiratory failure. In the present, we …

Pulmonary fibrosis (PF) is a chronic and irreversible interstitial lung disease that even
threatens the lives of some patients infected with COVID-19. PF is a multicellular …

Ethnopharmacological relevance Idiopathic pulmonary fibrosis (IPF) is a progressive
fibrosing pulmonary disorder that has a poor prognosis and high mortality. Although there …